BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  Circassia Stock Crashes as Allergy Drug Flunks Crucial Phase III Study

  June 20, 2016

   · 

  6 min read
• Novartis AG Pledges to Nearly Triple Biosimilar Drugs on Market By 2020

  June 20, 2016

   · 

  1 min read
• Business

  Backed by Novartis AG and Novo Nordisk A/S, UK Biotech F2G Bags $60 Million

  June 20, 2016

   · 

  3 min read
• Business

  Soligenix Taps a New CFO

  June 20, 2016

   · 

  5 min read
• Drug Development

  Global Blood Therapeutics Announces Initiation Of Phase 2a Study Of GBT440 In Idiopathic Pulmonary Fibrosis

  June 20, 2016

   · 

  5 min read
• BioCapital

  Kit Check Closes $15 Million Series C Round

  June 20, 2016

   · 

  2 min read
• Pharm Country

  Seventeen Days After Receiving FDA Approval, Braeburn Pharma Announces First Patients Have Received Probuphine (Buprenorphine) Implant

  June 20, 2016

   · 

  6 min read
• Drug Development

  Concordia Healthcare Announces PDT With Photofrin Data And Provides Corporate Update

  June 20, 2016

   · 

  4 min read
• Pharm Country

  AFSTYLA - CSL Behrings Novel Recombinant Factor VIII Single Chain Therapy For Hemophilia A - Now Available In The U.S.

  June 20, 2016

   · 

  8 min read
• Business

  VistaGen Therapeutics, Inc. Appoints Pharmaceutical CNS Drug Development Executive Mark A. Smith M.D., Ph.D. As Chief Medical Officer

  June 20, 2016

   · 

  6 min read